U.S. Medical Device Testing Services Market to Reach USD 7.05 Billion by 2035 at a 10.16% CAGR, While Europe Benefits from ...

Polyrizon is a development-stage biotech company that specializes in medical device hydrogels delivered as nasal sprays. The company’s proprietary Capture and Contain hydrogel technology uses ...

Polyrizon Ltd. (Nasdaq: PLRZ) (the “Company” or “Polyrizon”), a development-stage biotech company specializing in the development of innovative intranasal hydrogels, today announced successful results ...

Raanana, Israel, July 02, 2026 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) (the "Company” or "Polyrizon”), a development-stage biotech company specializing in the development of innovative ...

Polyrizon Ltd. (NASDAQ: PLRZ) shares gathered steam to begin Thursday trading. The development-stage biotech company specializing in the development of innovative intranasal hydrogels, today announced ...

Raanana, Israel, July 02, 2026 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) (the “Company” or “Polyrizon”), a development-stage biotech company specializing in the development of innovative ...